116 related articles for article (PubMed ID: 37714524)
21. Diffusion-weighted MRI improves response assessment after definitive radiotherapy in patients with NSCLC.
Jagoda P; Fleckenstein J; Sonnhoff M; Schneider G; Ruebe C; Buecker A; Stroeder J
Cancer Imaging; 2021 Jan; 21(1):15. PubMed ID: 33478592
[TBL] [Abstract][Full Text] [Related]
22. Redox ferrocenylseleno compounds modulate longitudinal and transverse relaxation times of FNPs-Gd MRI contrast agents for multimodal imaging and photo-Fenton therapy.
Zhou T; Zhang S; Zhang L; Jiang T; Wang H; Huang L; Wu H; Fan Z; Jing S
Acta Biomater; 2023 Jul; 164():496-510. PubMed ID: 37054962
[TBL] [Abstract][Full Text] [Related]
23. DNA-Templated Silver Nanocluster/Porphyrin/MnO
Yao Y; Li N; Zhang X; Ong'achwa Machuki J; Yang D; Yu Y; Li J; Tang D; Tian J; Gao F
ACS Appl Mater Interfaces; 2019 Apr; 11(15):13991-14003. PubMed ID: 30901195
[TBL] [Abstract][Full Text] [Related]
24. Quantitative T1 and T2 mapping in recurrent glioblastomas under bevacizumab: earlier detection of tumor progression compared to conventional MRI.
Lescher S; Jurcoane A; Veit A; Bähr O; Deichmann R; Hattingen E
Neuroradiology; 2015 Jan; 57(1):11-20. PubMed ID: 25287076
[TBL] [Abstract][Full Text] [Related]
25. Multistage O
Liang Y; Wang PY; Li YJ; Liu ZY; Wang RR; Sun GB; Sun HF; Xie SY
Int J Pharm; 2023 Jan; 631():122488. PubMed ID: 36521638
[TBL] [Abstract][Full Text] [Related]
26. Change in Apparent Diffusion Coefficient Is Associated With Local Failure After Stereotactic Body Radiation Therapy for Non-Small Cell Lung Cancer: A Prospective Clinical Trial.
Sampath S; Rahmanuddin S; Sahoo P; Frankel P; Boswell S; Wong J; Rotter A; Rockne R; Wong J; Park JM
Int J Radiat Oncol Biol Phys; 2019 Nov; 105(3):659-663. PubMed ID: 31271822
[TBL] [Abstract][Full Text] [Related]
27. A Targeted Multi-Crystalline Manganese Oxide as a Tumor-Selective Nano-Sized MRI Contrast Agent for Early and Accurate Diagnosis of Tumors.
Yang G; Xia J; Dai X; Zhao H; Gao W; Ding W; Tao X; Zhu L
Int J Nanomedicine; 2024; 19():527-540. PubMed ID: 38260241
[TBL] [Abstract][Full Text] [Related]
28. Gadolinium-Based Blood Volume Mapping From MRI With Ultrashort TE Versus CT and SPECT for Predicting Postoperative Lung Function in Patients With Non-Small Cell Lung Cancer.
Ohno Y; Yui M; Chen Y; Kishida Y; Seki S; Yoshikawa T
AJR Am J Roentgenol; 2019 Jan; 212(1):57-66. PubMed ID: 30422708
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic impact of integrated 18F-FDG PET/MRI in cerebral staging of patients with non-small cell lung cancer.
Deuschl C; Nensa F; Grueneisen J; Poeppel TD; Sawicki LM; Heusch P; Gramsch C; Mönninghoff C; Quick HH; Forsting M; Umutlu L; Schlamann M
Acta Radiol; 2017 Aug; 58(8):991-996. PubMed ID: 28273734
[TBL] [Abstract][Full Text] [Related]
30. [Preoperative T stage of non-small cell lung cancer: comparison of the efficacy of 64-MDCT versus 3.0T MR imaging].
Tang W; Wu N; Ouyang H; Huang Y; Liu L; Li M; Zhou L; Xu X
Zhonghua Zhong Liu Za Zhi; 2015 Aug; 37(8):617-21. PubMed ID: 26714604
[TBL] [Abstract][Full Text] [Related]
31. Tumor microenvironment responsive theranostic agent for enhanced chemo/chemodynamic/photothermal therapy.
Wang J; Kong W; Jin H; Li C; Luo Q; Luo Y; Yuan C; Lu J; Zhang L; Liu X
Colloids Surf B Biointerfaces; 2022 Oct; 218():112750. PubMed ID: 35961116
[TBL] [Abstract][Full Text] [Related]
32. PDGFB-targeted functional MRI nanoswitch for activatable T
Zhang Y; Liu L; Li W; Zhang C; Song T; Wang P; Sun D; Huang X; Qin X; Ran L; Tian G; Qian J; Zhang G
J Nanobiotechnology; 2023 Jan; 21(1):9. PubMed ID: 36609374
[TBL] [Abstract][Full Text] [Related]
33. Mesoporous manganese silicate coated silica nanoparticles as multi-stimuli-responsive T1-MRI contrast agents and drug delivery carriers.
Li X; Zhao W; Liu X; Chen K; Zhu S; Shi P; Chen Y; Shi J
Acta Biomater; 2016 Jan; 30():378-387. PubMed ID: 26602820
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of NOLC1 as a potential target for enhancing sensitivity in multidrug resistant non-small cell lung cancer cells.
Huang H; Li T; Chen M; Liu F; Wu H; Wang J; Chen J; Li X
Cell Mol Biol Lett; 2018; 23():54. PubMed ID: 30505321
[TBL] [Abstract][Full Text] [Related]
35. Improving the sensitivity of
Yang L; Wang L; Huang G; Zhang X; Chen L; Li A; Gao J; Zhou Z; Su L; Yang H; Song J
Theranostics; 2021; 11(14):6966-6982. PubMed ID: 34093865
[No Abstract] [Full Text] [Related]
36. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
[TBL] [Abstract][Full Text] [Related]
37. Multiparametric Differentiation of Idiopathic Dilated Cardiomyopathy With and Without Congestive Heart Failure by Means of Cardiac and Hepatic T1-Weighted MRI Mapping.
Huber AT; Razakamanantsoa L; Lamy J; Giron A; Cluzel P; Kachenoura N; Redheuil A
AJR Am J Roentgenol; 2020 Jul; 215(1):79-86. PubMed ID: 32208004
[No Abstract] [Full Text] [Related]
38. Affibody-Modified Gd@C-Dots with Efficient Renal Clearance for Enhanced MRI of EGFR Expression in Non-Small-Cell Lung Cancer.
Wu Y; Li H; Yan Y; Wang K; Cheng Y; Li Y; Zhu X; Xie J; Sun X
Int J Nanomedicine; 2020; 15():4691-4703. PubMed ID: 32636625
[TBL] [Abstract][Full Text] [Related]
39. Manganese Oxide Nanoparticles As MRI Contrast Agents In Tumor Multimodal Imaging And Therapy.
Cai X; Zhu Q; Zeng Y; Zeng Q; Chen X; Zhan Y
Int J Nanomedicine; 2019; 14():8321-8344. PubMed ID: 31695370
[TBL] [Abstract][Full Text] [Related]
40. Bimodal Phosphorescence-Magnetic Resonance Imaging Nanoprobes for Glutathione Based on MnO
Shi W; Song B; Shi W; Qin X; Liu Z; Tan M; Wang L; Song F; Yuan J
ACS Appl Mater Interfaces; 2018 Aug; 10(33):27681-27691. PubMed ID: 30058801
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
